Search Results for: "Other News to Note"
-
Other News To Note
At the maximum dose, Jentadueto showed placebo-adjusted HbA1c reductions up to 1.7 percent in clinical trials...The move is part of the National Institutes of Health's plan to leverage its HIV clinical trial networks to enroll both HIV-uninfected and HIV-infected tuberculosis patients in various clinical trialsBioWorld Today | Wednesday, February 1, 2012 -
Other News To Note
The proceeds will be used to complete ongoing clinical trialsBioWorld International | Wednesday, January 25, 2012 -
Other News To Note
GCS-100 started clinical trials with IGG International IncBioWorld Today | Monday, January 23, 2012 -
Other News To Note
Clinical trials in cancer are expected to start this yearBioWorld Today | Wednesday, January 18, 2012 -
Other News To Note
The study, funded by the European and Developing Countries Clinical Trials Partnership, is being conducted in collaboration with several groups, including the South African TB Vaccine InitiativeBioWorld International | Wednesday, January 18, 2012 -
Other News To Note
Spherix Inc., of Bethesda, Md., said it completed a 28-day rat toxicology study of potential dyslipidemia compound SPX-106 and found "an ample margin of safety" with the dosing planned for its first clinical trialBioWorld Today | Thursday, January 12, 2012 -
Other News To Note
The goal is to initiate clinical trials with one or more molecules in the near future...The samples will be used in the development of companion diagnostic assays for folate receptor alpha, the target of Morphotek's lead candidate, farletuzumab, which is being tested in several clinical trials against different types of cancers, including non-small-cell lung adenocarcinoma and ovarian carcinomaBioWorld Today | Wednesday, January 11, 2012 -
Other News To Note
Affitech A/S, of Copenhagen, Denmark, said its Russian partner, IBC Generium, submitted a clinical trial application to the Russian Health Authority to begin a Phase Il trial with Affitech's lead monoclonal antibody candidate AT001/r84BioWorld International | Wednesday, January 11, 2012 -
Other News To Note
Under the agreement, the NCI and Micromet will collaborate on a series of clinical trials to evaluate the safety and efficacy of blinatumomab in patients with B-cell derived hematologic malignanciesBioWorld Today | Tuesday, January 10, 2012 -
Other News To Note
The response includes data and analyses from Arena's Phase III BLOOM-DM (Behavioral modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus) clinical trial, which evaluated lorcaserin for weight loss in patients with Type II diabetes. (See BioWorld Today, Jan. 31, 2011, and Dec. 23, 2010BioWorld Today | Thursday, January 5, 2012 -
Other News To Note
Roche demonstrated efficacy in lowering blood glucose levels of diabetic patients in clinical trials using a previous generation of its GKA compoundsBioWorld International | Wednesday, December 28, 2011 -
Other News To Note
Roche demonstrated efficacy in lowering blood glucose levels of diabetic patients in clinical trials using a previous generation of its GKA compoundsBioWorld Today | Wednesday, December 21, 2011 -
Other News To Note
The goal is then to license promising candidates to other pharmaceutical companies for advanced clinical development and commercialization...In other news, GSK and Human Genome Sciences Inc., of Rockville, Md., said they started dosing in BLISS-SC, a new Phase III trial of Benlysta (belimumab) administered subcutaneously once weekly to autoantibody-positive adults with active systemic lupus erythematosus (SLEBioWorld International | Wednesday, December 21, 2011 -
Other News To Note
To-BBB recently initiated a clinical trial with 2B3-101 for primary and metastatic brain tumorsBioWorld Today | Tuesday, December 20, 2011 -
Other News To Note
The firms entered a potential $213.6 million worldwide collaboration in January 2010 to discover and develop treatments for hearing loss and balance disorders and added a $13 million supply agreement in August 2010 to manufacture clinical trial material for up to two lead candidates. (See BioWorld Today, Jan. 20, 2010BioWorld Today | Wednesday, December 7, 2011 -
Other News To Note
Boehringer Ingelheim will produce ficlatuzumab for clinical trials at its biopharmaceutical site in Fremont, Calif., with AVEO retaining all rights to the compound's development and commercialization...In clinical trials, Eurartesim performed better, with a cure rate above 95 percent, and provided longer protection from new malaria infections than other approved ACTsBioWorld International | Wednesday, December 7, 2011 -
Other News To Note
NanoViricides Inc., of West Haven, Conn., requested a pre-investigational new drug meeting with the FDA to review its plan for safety/toxicology studies and clinical trials of its anti-influenza candidate, FluCideBioWorld Today | Tuesday, December 6, 2011 -
Other News To Note
Boehringer Ingelheim will produce ficlatuzumab for clinical trials at its biopharmaceutical site in Fremont, Calif., with AVEO retaining all rights to the compound's development and commercializationBioWorld Today | Friday, December 2, 2011 -
Other News To Note
In clinical trials, Eurartesim performed better, with a cure rate above 95 percent, and provided longer protection from new malaria infections than other approved ACTsBioWorld Today | Thursday, December 1, 2011 -
Other News To Note
Civitas, a spinoff from Alkermes Inc., of Waltham, Mass., said clinical trials of CVT-301 would begin this year. (See BioWorld Today, Jan. 10, 2011BioWorld Today | Wednesday, November 30, 2011
Category
Current Filters
- xclinical trials
Related Keywords
Categories
- x BioWorld Today (1934)
- x BioWorld International (411)
- x Bio Perspectives (4)
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.